Spots Global Cancer Trial Database for Decisions About Cancer Screening in Alzheimer's Disease
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Decisions About Cancer Screening in Alzheimer's Disease
Official Title: Decisions About Cancer Screening in Alzheimer's Disease
Study ID: NCT03282097
Conditions
Study Description
Brief Summary: The Decisions about Cancer screening in Alzheimer's Disease (DECAD) study is the first study to test if an evidence-based decision aid for AD caregivers can support decision-making about mammography and improve the quality of medical decision-making about breast cancer screening. This large randomized controlled trial will recruit up to 450 dyads (900 individual participants) of older women with AD and a family caregiver, for a goal of 426 dyad baselines (852 individual participants), from 24 primary care practices in central Indiana to test this decision aid.
Detailed Description:
Keywords
Eligibility
Minimum Age: 75 Years
Eligible Ages: OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Parkview Health, Fort Wayne, Indiana, United States
Alzheimer's Association, Indianapolis, Indiana, United States
Eskenazi Health, Indianapolis, Indiana, United States
IU Health, Indianapolis, Indiana, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Contact Details
Name: Nicole Fowler, PhD
Affiliation: Indiana University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
